Organogenesis Holdings (ORGO) Shares Outstanding (2015 - 2026)

Organogenesis Holdings has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $128.7 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 1.44% year-over-year to $128.7 million in Q2 2026; TTM through Jun 2026 was $128.7 million, a 1.44% increase from a year earlier, with the FY2025 full-year figure at $127.0 million, up 0.97% from the prior year.
• Shares Outstanding (Entity) was $128.7 million for Q2 2026 at Organogenesis Holdings, roughly flat from $128.7 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $132.6 million in Q3 2024, with the low at $125.7 million in Q4 2024.
• Average Shares Outstanding (Entity) over 5 years is $129.7 million, with a median of $130.9 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 2.03% in 2022, then fell 4.32% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $130.9 million in 2022, then increased by 0.3% to $131.3 million in 2023, then retreated by 4.25% to $125.7 million in 2024, then grew by 0.97% to $127.0 million in 2025, then grew by 1.36% to $128.7 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $128.7 million (Q2 2026), $128.7 million (Q1 2026), and $127.0 million (Q4 2025), per Business Quant data.